Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines.
Although canine osteosarcoma is one of the most malignant, aggressive and lethal neoplasms originating from undifferentiated bone cells, it may retain some capacity for normal differentiation. The purpose of this study was to ascertain if the residual capacity for differentiation could be used to suppress its malignant properties. We tested the efficacy of vitamin D and retinoids in inducing differentiation and inhibiting growth of the POS canine osteosarcoma and four of its clonal cell lines, POS 14A (fibroblast type), POS 53B (chondroblast type), POS 53C (undifferentiated type) and POS 53D (osteoblastic type). Treatment with 10(-10)to 10(-8)M concentrations of calcitriol, OCT, cholecalciferol, all-trans retinoic acid (ATRA) and 9-cis retinoic acid for 48-120 hours changed the morphology of POS, POS 53B, POS 53C and POS 53D cells to cells that were elongated and spindle-shaped. Increased number of cytoplasmic organelles and pronounced nuclear activities were induced by concentrations of 10(-8)M and 10(-7)M for 120 hours. All drugs at concentrations of 10(-10)to 10(-8)M for 72 hours inhibited POS growth dose-dependently. OCT significantly reduced the cell number in all cell lines when used at concentrations between 10(-9)and 10(-8)M for 72 hours and exerted significant anti-proliferative effects for eight days culture. This study demonstrated that changed morphology and inhibition of growth was induced by treatment of the cells with these vitamins, that the loss of control of differentiation in the neoplasia was not irreversible and that these drugs may be useful in the clinic.
Barroga
E F
EF
Laboratory of Veterinary Surgery, Department of Veterinary Clinical Sciences, Hokkaido University, Sapporo, 060-0818, Japan.
Kadosawa
T
T
Okumura
M
M
Fujinaga
T
T
D000818:Animals; D001859:Bone Neoplasms / Q000473:pathology / Q000662:veterinary*; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002999:Clone Cells; D004283:Dog Diseases / Q000473:pathology*; D004285:Dogs; D008854:Microscopy, Electron / Q000662:veterinary; D008858:Microscopy, Phase-Contrast / Q000662:veterinary; D012516:Osteosarcoma / Q000473:pathology / Q000662:veterinary*; D012176:Retinoids / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D014807:Vitamin D / Q000494:pharmacology*
D012176:Retinoids; D014807:Vitamin D